COLLA-TEC, INC. – Trademark Portfolio

Entity Type: 03

COLLA-TEC, INC. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include BIOMEND, HELITENE, COLLAPLUG, and COLLATAPE. The owner is based in PLAINSBORO, NJ.

P. O. BOX 688

105 MORGAN DRIVE

PLAINSBORO, NJ 08536

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

COLLA-TEC, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (9 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does COLLA-TEC, INC. have?

COLLA-TEC, INC. has 10 U.S. trademarks filed with the USPTO. Of these, 4 registered, 4 abandoned, 2 cancelled.

What trademark classes does COLLA-TEC, INC. file in?

COLLA-TEC, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are COLLA-TEC, INC.'s most well-known trademarks?

COLLA-TEC, INC.'s registered trademark portfolio includes well-known marks such as BIOMEND, HELITENE, COLLAPLUG, and COLLATAPE. These are among 4 currently registered trademarks in the portfolio.

What is COLLA-TEC, INC.'s trademark registration success rate?

COLLA-TEC, INC. has a 40% trademark registration rate, with 4 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.